Investigating the role of PLK4 in melanoma treatment
Functional and Therapeutic Significance of PLK4 in Melanoma
This study is looking at a protein called PLK4 to see if blocking it could help treat melanoma, a serious skin cancer, and it aims to find new ways to improve treatment for patients who aren't responding well to current options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10848386 on NIH RePORTER |
What this research studies
This research focuses on understanding how polo-like kinase 4 (PLK4) can be targeted for treating melanoma, a serious skin cancer. The study aims to explore the mechanisms by which PLK4 interacts with other pathways involved in melanoma progression and whether inhibiting PLK4 can provide a new therapeutic approach. By examining the role of PLK4 in the transformation of melanocytes and the development of melanoma, the research seeks to identify potential new treatments that could overcome resistance to existing therapies. Patients may benefit from insights into more effective management strategies for melanoma.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with melanoma, especially those with advanced stages or those who have not responded well to existing treatments.
Not a fit: Patients with early-stage melanoma or those who do not have the specific genetic mutations being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for melanoma patients, particularly those who have developed resistance to current therapies.
How similar studies have performed: While the role of PLK4 in cancer treatment is being explored, this specific approach to targeting PLK4 in melanoma is relatively novel and has not been extensively tested in clinical settings.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Ahmad, Nihal — University of Wisconsin-Madison
- Study coordinator: Ahmad, Nihal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.